FDA-issued sodium targets yield no apparent impact

In 2021, the U.S. Food and Drug Administration (FDA) issued Phase I voluntary sodium simplification targets to promote manufacturers to little the magnitude of sodium successful packaged nutrient products by 2024. The targets look to person had minimal impact, according to a survey comparing the sodium contented of caller products introduced earlier and aft the guidance was issued.